Tzianabos Arthur's Form 4 filing
Q32 Bio Inc. (QTTB) · filed Aug 14, 2024
- Accession no.
- 0000950170-24-096986
- Filed
- Aug 14, 2024
- Trade date
- Mar 25, 2024
- Filing delay
- 142 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $6.41K. It was filed 142 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tzianabos ArthurCIK 0001586226 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 25, 2024 | Common Stock | MOption exerciseAcquired | +1,095 | – | – | 8,248 | Direct | |
| Mar 25, 2024 | Common Stock | SSaleDisposed | −265 | $24.20 | −$6,413 | 7,983 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 25, 2024 | Common Stock | MOption exerciseDisposed | −1,095 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.